 Lung Neoplasms
"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 12 | 3 | 15 | | 1996 | 15 | 4 | 19 | | 1997 | 21 | 2 | 23 | | 1998 | 14 | 2 | 16 | | 1999 | 11 | 1 | 12 | | 2000 | 13 | 1 | 14 | | 2001 | 13 | 8 | 21 | | 2002 | 39 | 8 | 47 | | 2003 | 22 | 3 | 25 | | 2004 | 34 | 5 | 39 | | 2005 | 38 | 4 | 42 | | 2006 | 38 | 9 | 47 | | 2007 | 40 | 7 | 47 | | 2008 | 38 | 5 | 43 | | 2009 | 39 | 4 | 43 | | 2010 | 50 | 3 | 53 | | 2011 | 42 | 4 | 46 | | 2012 | 59 | 4 | 63 | | 2013 | 67 | 10 | 77 | | 2014 | 66 | 7 | 73 | | 2015 | 60 | 9 | 69 | | 2016 | 73 | 8 | 81 | | 2017 | 71 | 7 | 78 | | 2018 | 78 | 8 | 86 | | 2019 | 74 | 4 | 78 | | 2020 | 77 | 3 | 80 | | 2021 | 71 | 2 | 73 | | 2022 | 76 | 1 | 77 | | 2023 | 62 | 1 | 63 | | 2024 | 46 | 5 | 51 | | 2025 | 23 | 1 | 24 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Hirsch EA, Studts JL, Zane S, McCreight M, Huebschmann AG. Evaluating Pragmatism of Lung Cancer Screening Randomized Trials with the PRECIS-2 Tool. J Am Board Fam Med. 2025 May 12; 38(1):56-83.
-
Girard N, Xu Q, Camidge DR, Baijal S, Ng S, Kamalakar R, Ratajczak C, Alhasani H, Crawford S, Karve S, Lu S. Real-world treatment and outcomes for EGFR WT advanced/metastatic non-squamous non-small cell lung cancer: pooled analysis from project LUMINATE-101. Oncologist. 2025 May 08; 30(5).
-
Xu Y, Yang JC, Zhao Y, Doucet L, Zhou J, Wang Y, Planchard D, Fan Y, Jin B, Han Z, Greillier L, Mazieres J, Sun M, Hu Y, Song X, Ding C, Wu L, Tang K, Liang L, Yao Y, Cheng Y, He Y, Ferreira BP, Ghiringhelli F, Felip E, Bosch-Barrera J, Liu A, Yu Y, Dong X, Gao J, Camidge DR, Nian W, Zhou C, Yang R, John T, Gao B, Bazhenova L, Nagasaka M, Wang J, Ren X, Xu F, Li W, Zhao D, Wang H, Sun S, Huang J, Zhu X, Zheng L, J?nne PA, Wang M. Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation. Cell Rep Med. 2025 May 20; 6(5):102121.
-
Li C, Syed MU, Nimbalkar A, Shen Y, Vieira MD, Fraser C, Inde Z, Qin X, Ouyang J, Kreuzer J, Clark SE, Kelley G, Hensley EM, Morris R, Lazaro R, Belmonte B, Oh A, Walcott M, Nabel CS, Caenepeel S, Saiki AY, Rex K, Lipford JR, Heist RS, Lin JJ, Haas W, Sarosiek K, Hughes PE, Hata AN. LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers. Nat Commun. 2025 May 02; 16(1):4112.
-
Madan R, El Alam RH, Walker CM, Bang TJ, Bartel TB, Batra K, Brixey AG, Christensen JD, Cox CW, Gonzalez AV, Little BP, Lui NS, Maxfield H, Moore WH, Qin A, Shroff GS, Yasufuku K, Chung JH. ACR Appropriateness Criteria? Lung Cancer-Surveillance After Therapy. J Am Coll Radiol. 2025 May; 22(5S):S319-S342.
-
Barsouk A, Elghawy O, Watts A, Reed-Guy L, Tompkins W, Chandrasekhara K, Grady CB, Iams W, Sun F, Liu G, Patel D, Nieva JJ, Marrone KA, Velcheti V, Liu SV, Patil T, Weiss J, Schwartzman W, Villaruz LC, Hermann A, Aisner DL, Hwang WT, Camidge DR, Sun L, Singh AP, Cohen RB, Aggarwal C, Langer CJ, Marmarelis ME. Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis. Lung Cancer. 2025 May; 203:108551.
-
Stuart CM, Meguid RA, Rove JY. Noteworthy in Cardiothoracic Surgery 2024. Semin Cardiothorac Vasc Anesth. 2025 Jun; 29(2):126-133.
-
Thomas NA, New ML. Biomarkers in lung cancer diagnosis and bronchoscopy: Current landscape and future directions. Cancer Biomark. 2025 Jan; 42(1):18758592241306682.
-
Disher N, Dieckmann NF, Case JR, Rubim F, Eden KB, Golden SE, Matlock DD, Coleman C, Lyons KS, Saha S, Slatore CG, Vranas KC, Sullivan DR. Improving lung cancer decision-making using a conversation tool (iDECIDE): a stepped wedge pragmatic clinical trial. Future Oncol. 2025 Apr; 21(9):1045-1056.
-
Cho BC, Johnson M, Bar J, Schaefer E, Yoh K, Zer A, Moskovitz M, Lee SH, Moreno V, de Miguel M, Okuma Y, Kim JH, Lee CH, Peguero J, Ansell P, Biesdorf C, Saab R, Freise KJ, Ramies D, Jeng EE, Camidge DR. A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer. Lung Cancer. 2025 Apr; 202:108492.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|